Enhancing Anti-Tumor Immunity In Vivo with Gamma Delta T cells

Meet the Team

  • Nizar Batada

    CEO/Co-Founder

    Training

    PhD, Stanford
    Postdoc, Harvard


    Expertise

    Computational Genomics and Immunology
    (Previously at 23andMe Therapeutics)

    Linkedin

  • Yoshi Fukazawa

    VP of Research / Co-Founder

    Training

    PhD, Kyoto
    Postdoc, Oregon Health & Science University

    Expertise

    Disease and functional Immunology (previously at Cytek)

    Linkedin

  • George Church

    Scientific Advisor / Co-Founder

    Training

    Professor, Harvard Medical School


    Experience

    Pioneer in Genomics, Synthetic Biology, and Genome Editing

    Linkedin